A Phase III, Multicenter, Randomized, Double-blind, Parallel Group, Active Treatment-controlled Study Assessing the Safety and Efficacy of G238 Compared to Clotrimazole 1% Otic Solution in Patients With Otomycosis

Trial Profile

A Phase III, Multicenter, Randomized, Double-blind, Parallel Group, Active Treatment-controlled Study Assessing the Safety and Efficacy of G238 Compared to Clotrimazole 1% Otic Solution in Patients With Otomycosis

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Apr 2017

At a glance

  • Drugs G 238 (Primary) ; Clotrimazole
  • Indications Mycoses
  • Focus Registrational; Therapeutic Use
  • Sponsors SALVAT
  • Most Recent Events

    • 15 Apr 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 02 Sep 2014 Planned End Date changed from 1 Apr 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov record.
    • 02 Sep 2014 Planned primary completion date changed from 1 Apr 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top